Ledger.Open graph →
SEC Form D · Amendment · filed April 25, 2019

Guide Therapeutics, Inc

Offering
$6.0M
Sold
$6.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
ATLANTA, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Thomas R. Saylor · Atlanta, GAExec · DirectorJames R. Dahlman · Atlanta, GADirectorAndrew R. Perlman · Atlanta, GADirectorBoris R. Nikolic · Atlanta, GADirectorScott H. Morenstein · Wayne, PAExec · Directornull InvestX Master GP1, Inc · Vancouver, British Columbia, CanadaDirectorKathleen S. Goin · Wayne, PADirectorTanguy Serra · SAN FRANCISCO, CADirectorDavid N. Bartelme · Milwaukee, WIExec · DirectorSequoya N. Borgman · Milwaukee, WIDirectorBoris R. Nikolic · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗